USPTO Patent for Hair Follicle Regeneration

ChangeBridge: Patent Grants - Therapeutics (A61P)

Published March 24th, 2026

Detected March 24th, 2026

Summary

The USPTO has granted Washington University a patent (US12582649B2) for compositions and methods for hair follicle regeneration using TRPV4 activating agents. The patent aims to treat hair loss conditions such as alopecia and telogen effluvium.

View original document View source feed page

What changed

The United States Patent and Trademark Office (USPTO) has issued patent US12582649B2 to Washington University. This patent covers compositions and methods for treating hair loss and promoting hair growth by administering TRPV4 activating agents. The patent, filed under application number 18009050, has 22 claims and is classified under CPC codes related to pharmaceutical compositions and cosmetic preparations for hair growth.

This patent grant is primarily an intellectual property matter and does not impose direct compliance obligations on regulated entities. However, it signifies a new development in the therapeutic landscape for hair loss treatments. Companies operating in the pharmaceutical and cosmetic sectors, particularly those involved in R&D for hair growth products, should be aware of this patented technology, as it may impact future product development and market entry strategies.

Source document (simplified)

← USPTO Patent Grants

Compositions and methods for hair follicle regeneration

Grant US12582649B2 Kind: B2 Mar 24, 2026

Assignee

Washington University

Inventors

Hongzhen Hu

Abstract

Among the various aspects of the present disclosure is the provision of compositions and methods for treating hair regeneration disorders or conditions such as hair loss or thinning. An aspect of the present disclosure provides for a method of treating hair loss, promoting hair growth, or treating hair loss, such as alopecia or telogen effluvium, comprising administering a TRPV4 activating agent to a subject.